S'abonner

Heterogeneity of microvascular dysfunction in women with chest pain not attributable to coronary artery disease: Implications for clinical practice - 28/08/11

Doi : 10.1067/mhj.2003.95 
Oscar C. Marroquin, MDa, Richard Holubkov, PhDb, Daniel Edmundowicz, MDa, Cheryl Rickens, BSNa, Gerald Pohost, MDc, Steven Buchthal, PhDc, Carl J. Pepine, MDd, George Sopko, MDe, Robert C. Sembrat, BSf, Carolyn Cidis Meltzer, MDf, Steven E. Reis, MDa
From the aCardiovascular Institute, University of Pittsburgh, Pittsburgh, Pa, bDepartment of Family and Preventive Medicine, School of Medicine, University of Utah, Salt Lake City, Utah, cDivision of Cardiology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Ala, dDivision of Cardiology, Department of Medicine, University of Florida, Gainesville, Fla, eDivision of Heart and Vascular Diseases, National Heart, Lung and Blood Institutes, Bethesda, Md, and the fDepartment of Radiology, University of Pittsburgh, Pittsburgh, Pa. 

Abstract

Background Women with chest pain in the absence of obstructive coronary artery disease (CAD) frequently have coronary microvascular dysfunction and inducible myocardial ischemia. Microvascular dysfunction is commonly diagnosed by demonstrating abnormal flow reserve in a single coronary artery during angiography. Therefore, diagnostic accuracy is dependent on homogeneity of microvascular dysfunction in the myocardium. Methods In the Women's Ischemia Syndrome Evaluation (WISE), 34 women with chest pain and no significant CAD and 9 female control subjects underwent 13N-NH3 positron emission tomography to measure adenosine-induced changes in myocardial perfusion (ie, coronary flow reserve [CFR]). Flow reserve was correlated among the left anterior descending (LAD), circumflex (LCx), and right (RCA) coronary artery distributions. Results The mean CFR in the LAD, LCx, and RCA was 2.85 ± 1.35, 2.58 ± 0.94, and 3.24 ± 1.42, respectively. Concordance in the classification of microvascular function as normal (CFR ≥2.5) versus abnormal was present in the LAD and RCA, LAD and LCx, and RCA and LCx distributions in only 71.8%, 66.7%, and 61.6% of patients, respectively. There was a modest degree of correlation of CFR between the LAD and RCA (r = 0.79, P < .001), LAD and LCx (r = 0.61, P < .001), and LCx and RCA (r = 0.57, P < .001). Comparison of CFR in the 3 coronary arteries simultaneously in all patients demonstrated that the LCx had values that were significantly lower than the RCA and LAD distributions. Conclusion Substantial discordance of classification of microvascular function among coronary artery distributions in women with chest pain and no CAD suggests that microvascular dysfunction is distributed heterogeneously in the myocardium. Assessment of CFR in a single coronary artery during cardiac catheterization may not provide an accurate assessment of the coronary microcirculation in women with chest pain not attributable to CAD. (Am Heart J 2003;145:628-35.)

Le texte complet de cet article est disponible en PDF.

 Supported by the National Heart, Lung and Blood Institute contracts N01-HV-68161, N01-HV-68162, NO1-HV-68163, NO1-HV-68164 and grants from the Gustavis and Louis Pfeiffer Research Foundation; The Women's Guild, Cedars-Sinai Medical Center; Ladies Hospital Aid Society of Western Pennsylvania, University of Pittsburgh; and qmed, Inc.


© 2003  Mosby, Inc. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 145 - N° 4

P. 628-635 - avril 2003 Retour au numéro
Article précédent Article précédent
  • Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: Are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study
  • Gad Cotter, Christopher P. Cannon, Carolyn H. McCabe, Yoav Michowitz, Edo Kaluski, Andrew Charlesworth, Olga Milo, Jane Bentley, Alex Blatt, Rikardo Krakover, Reuven Zimlichman, Leonardo Reisin, Alon Marmor, Basil Lewis, Zvi Vered, Avi Caspi, Eugene Braunwald, OPUS-TIMI 16 Investigators
| Article suivant Article suivant
  • Effect of tenecteplase versus alteplase on platelets during the first 3 hours of treatment for acute myocardial infarction: The Assessment of the Safety and Efficacy of a New Thrombolytic Agent (ASSENT-2) platelet substudy
  • Victor L. Serebruany, Alex I. Malinin, Kevin P. Callahan, Azan Binbrek, Frans Van de Werf, John H. Alexander, Christopher B. Granger, Paul A. Gurbel

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.